Article

Ophtec Announces Modern New Brand Identity: Keeping Up with the Times

Author(s):

Celebrating 40-year anniversary with new brand/new products.

(Image Credit: AdobeStock/Blue Planet Studio)

(Image Credit: AdobeStock/Blue Planet Studio)

Ophtec, the Dutch manufacturer of intraocular lenses (IOLs) based in Groningen, is hitting the 40-year mark in 2023. To celebrate the event, the company is launching a new brand identity that is modernized and fit for the future, according to the company’s press release.

Marketing manager Remko Bos explains the reasons behind the rebranding, “Ophtec always had a full focus on making unique products. Our people are highly dedicated to support ophthalmologists to do their best job possible. Our branding was somehow underexposed. This year is a great moment for us to honor our heritage, fresh up our brand and connect to a new generation of eye-doctors.”

Bos describes the new brand as “quite a transformation,” with colors that catch the eye.

“New look, same focus, and an ingenious partner to ophthalmologists. Together, we help people to see clearly," said Bos.

Ophtec was founded in 1983 by Prof. Dr. Jan Worst, who invented the Artisan lens, the first iris-fixated IOL. To this day, the company remains family-owned.

“When my parents established Ophtec in 1983, it was their ambition to let surgeons and patients benefit from better products than were commonly available at the time,” Chief Executive Officer Erik Jan Worst commented. “And 40 years later we are still here. This makes me deeply proud and energized to lead the company into the future.”

The rebranding, which will become official on March 10, 2023, will be followed by the introduction of new products.

Worst announced the launch of ArtiPlus, a new iris-fixated presbyopia correction phakic IOL, in South Korea. A clinical study of the IOL is underway in Europe, and he described the results as “spectacular.”

Ophtec is also introducing a new pre-loaded injector system for the Precizon cataract lenses and after the summer the company expects to launch an exciting new lens concept.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.